Boston-based venture capital firm SV Life Sciences is working on its sixth fund, with a fundraising target of $400 million, according to a Form D filing on the U.S. Securities and Exchange Commission’s website. The firm invests in biotech, medical devices, health IT and healthcare services.
{iframe}http://medcitynews.com/2015/05/venture-capital-sv-life-sciences-medtech-biotech-healthit-startups/{/iframe}